NFKB1 and lymphoma: It remains to be seen whether the accumulation of non-selective somatic mutations observed in this patient is a general phenomenon in NFKB1 haploinsufficient patients and whether this contributes to an increased risk of GC B-cell derived lymphomas as has been observed (45) among 157 patients with heterozygous NKFB1 mutations (46–49).